| First Patient Treated In Adipose Stem & Regenerative Cell Study For Stress Urinary Incontinence (Medical News Today) |
|
|
Cytori (NASDAQ: CYTX) announced that the first patient was enrolled in an investigator-initiated safety and feasibility study using adipose-derived stem and regenerative cells to treat stress urinary incontinence. The 10-patient study is being conducted independently by Nagoya University Hospital in Japan. |